Pallas Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653K Sell
3,493
-922
-21% -$170K 0.02% 490
2026
Q1
$833K Sell
4,415
-2,485
-36% -$524K 0.03% 365
2025
Q4
$1.37M Buy
6,900
+693
+11% +$140K 0.05% 293
2025
Q3
$1.26M Buy
6,207
+1,713
+38% +$304K 0.05% 291
2025
Q2
$791K Buy
4,494
+2,209
+97% +$333K 0.03% 382
2025
Q1
$307K Buy
+2,285
New +$301K 0.01% 587
2024
Q4
– Sell
-2,804
Closed -$424K – 632
2024
Q3
$424K Buy
+2,804
New +$424K 0.02% 393

Other funds holding THC

Pallas Capital Advisors's THC Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Tenet Healthcare (THC) stake by 21% in Q2 2026, selling an estimated $170K and leaving 3,493 shares worth $653K. The position accounts for 0.02% of the portfolio, ranked #490.

Pallas Capital Advisors first reported a position in THC in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.37M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Pallas Capital Advisors held 3,493 shares of Tenet Healthcare worth $653K as of Q2 2026.
  • Pallas Capital Advisors sold 922 Tenet Healthcare shares in Q2 2026, an estimated $170K.
  • Tenet Healthcare made up 0.02% of Pallas Capital Advisors's portfolio in Q2 2026, its #490 holding.
  • Pallas Capital Advisors first reported a position in Tenet Healthcare in Q3 2024 and has held it in 7 quarters since.
  • Pallas Capital Advisors's Tenet Healthcare position peaked at $1.37M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.